top of page

COVID guidelines update and Antifungal prophylaxis guidelines

The MUHC ASP committee is happy to announce the update and publication of several guidelines:

  • Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg

  • COVID management guidelines (minor changes)

  • COVID outpatient decision tree : inclusion of situation in which to give Evusheld

  • Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)

We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.

Good reading to all and happy thanksgiving!

Francois Bourdeau, ASP co-chair

41 views0 comments

Recent Posts

See All

ASP committee developed a post-exposure prophylaxis (HIV, hepB & hepC) guidelines in collaboration with the CVIS team. It is available on our website! Francois Bourdeau ASP MUHC coordinator

The ASP committee updated the COVID guidelines. You will find the following change: -Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available. -Clar

bottom of page